The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCPT.L Regulatory News (CPT)

  • There is currently no data for CPT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Circular

8 Jul 2016 17:00

RNS Number : 7100D
Frontier Resources International
08 July 2016
 

Frontier Resources International Plc

("Frontier" or the "Company")

8 July 2016

Issue of Circular

The Board of Frontier (AIM Ticker: FRI) announces that the Company has today issued a circular convening a general meeting for 11.15am on Monday 25 July.

As previously announced on 7 July 2016, the Company) intends to tidy up its share capital by buying back all the deferred shares of 0.9p each and A deferred shares of 0.09p each in its share capital ("Deferred Shares") for the sum of £1 in aggregate ("Buy-Back"). 

The Deferred Shares were created because, due to earlier losses of capital, the market value of the Company's ordinary shares had dropped below their nominal value and, as company law does not permit a public limited company to issue shares at less than their nominal value, the Company could not raise new funding by the allotment of new ordinary shares. In order to enable the Company to issue new shares the nominal value of such ordinary shares was rebased and the excess share capital was applied in creating the Deferred Shares.

Under the terms of its articles of association ("Articles") the Company is entitled to buy back all of the Deferred Shares for £1 in aggregate. No shareholder is entitled to be paid any sum if the proceeds of sale of his Deferred Shares are less than 1p, and the Company does not anticipate any holder of Deferred Shares qualifying to receive any such proceeds. The Buy-Back has to be funded from the carried forward profits of the Company or a fresh issue of shares. As the Company does not have any carried forward profits, the Company has allotted 3,721 Ordinary Shares of 0.01p each at an issue price of 0.03p per Ordinary Share to Barbara Spurrier, one of its directors, in order to create the necessary proceeds to effect the Buy-Back. Once the Buy-Back has been completed the Deferred Shares will be cancelled, and the Ordinary Shares will constitute the only class of share capital in the Company.

Any Director of the Company is authorised under the Articles to execute a contract to effect the Buy-Back on behalf of all the holders of the Deferred Shares (the "Contract"). The Contract has to be approved by a special resolution of the ordinary shareholders of the Company. Under the Articles the Company is not required to seek the approval for the Buy-Back from the holders of the Deferred Shares. A copy of the Contract is on display at the Company's website at http://www.friplc.com/ and will remain on display for ten years from the date that the purchase of the Deferred Shares is completed.

The Company has convened a general meeting of the Company to be held at 11.15 a.m. on 25 July 2016 at Finsgate, 5-7 Cranwood Street, London EC1V 9EE, at which a special resolution to approve the Buy-Back and the Contract will be proposed ("General Meeting").

The board of directors of the Company is of the opinion that the above resolution to be proposed at the General Meeting (the "Resolution") is in the best interests of the Company and its shareholders as a whole. Accordingly, the Directors unanimously recommend that shareholders vote in favour of the Resolution, as the Directors intend to do in respect of their own beneficial shareholdings, which amount in aggregate to 537,097,355 ordinary shares of 0.03p each, representing approximately 10.41 per cent. of the existing ordinary share capital of the Company.

Enquiries:

Frontier Resources International Plc

Adam Reynolds, Chairman

Tel: +44 (0) 7785 908158

 

SPARK Advisory Partners Limited (Nomad)

Neil Baldwin/Mark Brady

Tel: +44 (0)20 368 3550

 

Beaufort Securities Limited (Broker) 

Jon Belliss

Tel: +44 (0)20 7382 8300

Yellow Jersey PR Limited (Financial PR)

Felicity Winkles/ Joe Burgess/ Josh Cole

Tel: +44 (0) 7748 843 871

 

A copy of this announcement is available from the Company's website www.friplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLVLFBQDFZBBD
Date   Source Headline
27th Sep 20187:00 amRNSInterim Results
21st Sep 20189:47 amRNSHolding(s) in Company
28th Aug 20187:00 amRNSHolding(s) in Company
13th Aug 201812:55 pmRNSHolding(s) in Company
13th Aug 20187:00 amRNSHolding(s) in Company
9th Aug 201812:15 pmRNSHolding(s) in Company
2nd Aug 20187:00 amRNSOversubscribed placing raises £2,000,000
17th Jul 20187:00 amRNSBoard Changes
14th Jun 201810:22 amRNSResult of AGM
22nd May 20185:13 pmRNSNotice of AGM
1st May 20187:00 amRNSFinal Results
26th Apr 201810:00 amRNSLogistics deal with major Chinese player SinoPharm
9th Apr 20188:25 amRNSConcepta manufacturing site achieves certification
29th Mar 20187:00 amRNSConcepta pre-launch myLotus in the UK
8th Mar 20187:00 amRNSmyLotus obtains approval to commence trial in UK
20th Feb 20187:00 amRNSLaunch of myLotus app in China
16th Feb 20187:00 amRNSTwo Senior Appointments and Grant of Options
15th Feb 20187:00 amRNSConcepta signs marketing contract in China
2nd Feb 20184:17 pmRNSHolding(s) in Company
29th Jan 20187:00 amRNSResults of Chinese hospital evaluations of myLotus
2nd Jan 201812:52 pmRNSChange of Broker
22nd Dec 201711:30 amRNSTrading update
14th Dec 20177:00 amRNSAssembly held in Shanghai to showcase myLotus
30th Nov 20173:05 pmRNSDirector/PDMR Shareholding
29th Nov 20179:02 amRNSHolding(s) in Company
13th Nov 20177:02 amRNSAppointment of Joint Corporate Broker
13th Nov 20177:01 amRNSOversubscribed equity fundraising of £2,000,000
13th Nov 20177:00 amRNSSales Order
6th Nov 201712:53 pmRNSTrading and Order Update
16th Oct 20177:00 amRNSmyLotus Fertility Product - China Update
19th Sep 20177:00 amRNSInterim Results
23rd Aug 201712:00 pmRNSCorporate Update
26th Jun 20177:00 amRNSDirector Shareholding
14th Jun 201712:00 pmRNSResult of AGM
13th Jun 20177:00 amRNSFirst Sales Order China and Trading Update
24th May 20174:58 pmRNSNotice of AGM
10th May 20177:00 amRNSFirst distributor agreement in China
26th Apr 20177:00 amRNSFinal Results
29th Mar 201710:00 amRNSUK Investor Show 2017
28th Mar 20177:00 amRNSDirectorate Changes
14th Feb 20171:45 pmRNSChange of Registered Office
7th Feb 20177:00 amRNSConcepta signs agreement with Selective Antibodies
9th Jan 20177:00 amRNSConcepta achieves ISO13485 accreditation
8th Dec 20167:00 amRNSAppointment China Country Manager
8th Nov 20167:09 amRNSNew manufacturing facility in Doncaster
10th Oct 20163:53 pmRNSIssue of Equity
26th Sep 20167:00 amRNSChinese Manufacturing Agreement Signed
21st Sep 20167:00 amRNSNew Laboratory Opening
18th Aug 20167:00 amRNSInterim Results
27th Jul 20164:11 pmRNSTR-1: Notification of major interest in shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.